Alboni S, Van DIjk RM, Poggini S, Milior G, Perrotta M, Drenth T, Brunello N, Wolfer DP, Limatola C, Amrein I, et al: Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment. Mol Psychiatry. 22:552–561. 2017.PubMed/NCBI View Article : Google Scholar

World Health Organization: Mental Disorders, 2022.

Isaac R, Boura-Halfon S, Gurevitch D, Shainskaya A, Levkovitz Y and Zick Y: Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells. J Biol Chem. 288:5682–5693. 2013.

Berardelli R, Margarito E, Ghiggia F, Picu A, Balbo M, Bonelli L, Giordano R, Karamouzis I, Bo M, Ghigo E and Arvat E: Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans. J Endocrinol Invest. 33:657–662. 2010.PubMed/NCBI View Article : Google Scholar

Ruhé HG, Khoenkhoen SJ, Ottenhof KW, Koeter MW, Mocking RJT and Schene AH: Longitudinal effects of the SSRI paroxetine on salivary cortisol in major depressive disorder. Psychoneuroendocrinology. 52:261–271. 2015.PubMed/NCBI View Article : Google Scholar

Dubovicky M, Belovicova K, Csatlosova K and Bogi E: Risks of using SSRI/SNRI antidepressants during pregnancy and lactation. Interdiscip Toxicol. 10:30–34. 2017.PubMed/NCBI View Article : Google Scholar

Avitsur R: Prenatal fluoxetine modifies the behavioral and hormonal responses to stress in male mice: Role for glucocorticoid insensitivity. Behav Pharmacol. 28:345–355. 2017.PubMed/NCBI View Article : Google Scholar

Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, et al: Selective serotonin reuptake inhibitors and adverse effects: A narrative review. Neurol Int. 13:387–401. 2021.PubMed/NCBI View Article : Google Scholar

Malagié I, Trillat AC, Jacquot C and Gardier AM: Effects of acute fluoxetine on extracellular serotonin levels in the raphe: An in vivo microdialysis study. Eur J Pharmacol. 286:213–217. 1995.PubMed/NCBI View Article : Google Scholar

Perez-Caballero L, Torres-Sanchez S, Bravo L, Mico JA and Berrocoso E: Fluoxetine: A case history of its discovery and preclinical development. Expert Opin Drug Discov. 9:567–578. 2014.PubMed/NCBI View Article : Google Scholar

Wille SMR, Cooreman SG, Neels HM and Lambert WEE: Relevant issues in the monitoring and the toxicology of antidepressants. Crit Rev Clin Lab Sci. 45:25–89. 2008.PubMed/NCBI View Article : Google Scholar

Catterson ML and Preskorn SH: Pharmacokinetics of selective serotonin reuptake inhibitors: Clinical relevance. Pharmacol Toxicol. 78:203–208. 1996.PubMed/NCBI View Article : Google Scholar

Benfield P, Heel RC and Lewis SP: Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 32:481–508. 1986.PubMed/NCBI View Article : Google Scholar

Reis M, Aamo T, Spigset O and Ahlner J: Serum concentrations of antidepressant drugs in a naturalistic setting: Compilation based on a large therapeutic drug monitoring database. Ther Drug Monit. 31:42–56. 2009.PubMed/NCBI View Article : Google Scholar

Gomez F and García-García L: Anxiogenic-like effects of fluoxetine render adult male rats vulnerable to the effects of a novel stress. Pharmacol Biochem Behav. 153:32–44. 2017.PubMed/NCBI View Article : Google Scholar

Alboni S, Benatti C, Montanari C, Tascedda F and Brunello N: Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus. Eur J Pharmacol. 721:158–167. 2013.PubMed/NCBI View Article : Google Scholar

Pawluski JL, Rayen I, Niessen NA, Kristensen S, van Donkelaar EL, Balthazart J, Steinbusch HW and Charlier TD: Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience. 220:131–141. 2012.PubMed/NCBI View Article : Google Scholar

Knaepen L, Rayen I, Charlier TD, Fillet M, Houbart V, van Kleef M, Steinbusch HW, Patijn J, Tibboel D, Joosten EA and Pawluski JL: Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring. PLoS One. 8(e57608)2013.PubMed/NCBI View Article : Google Scholar

Gemmel M, Hazlett M, Bögi E, De Lacalle S, Hill LA, Kokras N, Hammond GL, Dalla C, Charlier TD and Pawluski JL: Perinatal fluoxetine effects on social play, the HPA system, and hippocampal plasticity in pre-adolescent male and female rats: Interactions with pre-gestational maternal stress. Psychoneuroendocrinology. 84:159–171. 2017.PubMed/NCBI View Article : Google Scholar

Avitsur R, Grinshpahet R, Goren N, Weinstein I, Kirshenboim O and Chlebowski N: Prenatal SSRI alters the hormonal and behavioral responses to stress in female mice: Possible role for glucocorticoid resistance. Horm Behav. 84:41–49. 2016.PubMed/NCBI View Article : Google Scholar

Ghaeli P, Shahsavand E, Mesbahi M, Kamkar MZ, Sadeghi M and Dashti-Khavidaki S: Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. J Clin Psychopharmacol. 24:386–388. 2004.PubMed/NCBI View Article : Google Scholar

Pan SJ, Tan YL, Yao SW, Xin Y, Yang X, Liu J and Xiong J: Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression. Acta Pharmacol Sin. 39:1463. 2018.PubMed/NCBI View Article : Google Scholar

Masand PS and Gupta S: Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry. 14:175–182. 2002.PubMed/NCBI View Article : Google Scholar

Shahsavand Ananloo E, Ghaeli P, Kamkar MZ and Sadeghi M: Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression. Daru. 21(4)2013.PubMed/NCBI View Article : Google Scholar

Biagetti B and Corcoy R: Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes. World J Clin Cases. 1:169–171. 2013.PubMed/NCBI View Article : Google Scholar

Giri D, Price V, Yung Z, Didi M and Senniappan S: Fluoxetine-induced hypoglycaemia in a patient with congenital hyperinsulinism on lanreotide therapy. J Clin Res Pediatr Endocrinol. 8:347–350. 2016.PubMed/NCBI View Article : Google Scholar

Andersohn F, Schade R, Suissa S and Garbe E: Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 166:591–598. 2009.PubMed/NCBI View Article : Google Scholar

Sawka AM, Burgart V and Zimmerman D: Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride. J Pediatr. 136:394–396. 2000.PubMed/NCBI View Article : Google Scholar

Deeg MA and Lipkin EW: Hypoglycemia associated with the use of fluoxetine. West J Med. 164:262–263. 1996.PubMed/NCBI

Preeti S, Jayaram SD and Chittaranjan A: Sexual dysfunction in patients with antidepressant-treated anxiety or depressive disorders: A pragmatic multivariable longitudinal study. East Asian Arch Psychiatry. 28:9–16. 2018.PubMed/NCBI

AlBreiki M, Al Maqbali M, AlRisi K, AlSinawi H, AlBalushi M and Al Zakwani W: Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital. Neurosciences (Riyadh). 25:55–60. 2020.PubMed/NCBI View Article : Google Scholar

Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD and Ahn TY: Disorders of orgasm and ejaculation in men. J Sex Med. 7:1668–1686. 2010.PubMed/NCBI View Article : Google Scholar

Solomon R, Shvartsur R and Azab AN: The association between psychotropic drug use and fertility problems among male subjects. J Psychiatr Pract. 25:22–33. 2019.PubMed/NCBI View Article : Google Scholar

Trenque T, Maura G, Herlem E, Vallet C, Sole E, Auriche P and Drame M: Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: An example of underreporting. Drug Saf. 36:515–519. 2013.PubMed/NCBI View Article : Google Scholar

Relwani R, Berger D, Santoro N, Hickmon C, Nihsen M, Zapantis A, Werner M, Polotsky AJ and Jindal S: Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. Reprod Sci. 18:391–397. 2011.PubMed/NCBI View Article : Google Scholar

Safarinejad MR: Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J Urol. 180:2124–2128. 2008.PubMed/NCBI View Article : Google Scholar

Moore CJ, DeLong NE, Chan KA, Holloway AC, Petrik JJ and Sloboda DM: Perinatal administration of a selective serotonin reuptake inhibitor induces impairments in reproductive function and follicular dynamics in female rat offspring. Reprod Sci. 22:1297–1311. 2015.PubMed/NCBI View Article : Google Scholar

Ayala ME, Gonzáles A, Olivarez RM and Aragón-Martínez A: Fluoxetine treatment of prepubertal male rats uniformly diminishes sex hormone levels and, in a subpopulation of animals, negatively affects sperm quality. Reprod Fertil Dev. 30:1329–1341. 2018.PubMed/NCBI View Article : Google Scholar

de Oliveira WM, de Sá IR, de Torres SM, de Morais RN, Andrade AM, Maia FC, Tenorio BM and da Silva Junior VA: Perinatal exposure to fluoxetine via placenta and lactation inhibits the testicular development in male rat offspring. Syst Biol Reprod Med. 59:244–250. 2013.PubMed/NCBI View Article : Google Scholar

Elsedawi BF, Hussein Y, Sabry MA and Aziz JA: Effect of fluoxetine on the testes of adult albino rats and the possible protective role of curcumin. Anat Sci Int. 96:187–196. 2021.PubMed/NCBI View Article : Google Scholar

Erdemir F, Atilgan D, Firat F, Markoc F, Parlaktas BS and Sogut E: The effect of sertraline, paroxetine, fluoxetine and escitalopram on testicular tissue and oxidative stress parameters in rats. Int Braz J Urol. 40:100–108. 2014.PubMed/NCBI View Article : Google Scholar

Sakr HF, Abbas AM, Elsamanoudy AZ and Ghoneim FM: Effect of fluoxetine and resveratrol on testicular functions and oxidative stress in a rat model of chronic mild stress-induced depression. J Physiol Pharmacol. 66:515–527. 2015.PubMed/NCBI

Câmara ML, Almeida TB, de Santi F, Rodrigues BM, Cerri PS, Beltrame FL and Sasso-Cerri E: Fluoxetine-induced androgenic failure impairs the seminiferous tubules integrity and increases ubiquitin carboxyl-terminal hydrolase L1 (UCHL1): Possible androgenic control of UCHL1 in germ cell death? Biomed Pharmacother. 109:1126–1139. 2019.PubMed/NCBI View Article : Google Scholar

Monteiro Filho WO, de Torres SM, Amorim MJ, Andrade AJ, de Morais RN, Tenorio BM and da Silva Junior VA: Fluoxetine induces changes in the testicle and testosterone in adult male rats exposed via placenta and lactation. Syst Biol Reprod Med. 60:274–281. 2014.PubMed/NCBI View Article : Google Scholar

dos Santos AH, Vieira ML, de Azevedo Camin N, Anselmo-Franci JA, Ceravolo GS, Pelosi GG, Moreira EG, Kiss AC, Mesquita Sde F and Gerardin DC: In utero and lactational exposure to fluoxetine delays puberty onset in female rats offspring. Reprod Toxicol. 62:1–8. 2016.PubMed/NCBI View Article : Google Scholar

Romero-Reyes J, Cárdenas M, Damián-Matsumura P, Domínguez R and Ayala ME: Inhibition of serotonin reuptake in the prepubertal rat ovary by fluoxetine and effects on ovarian functions. Reprod Toxicol. 59:80–88. 2016.PubMed/NCBI View Article : Google Scholar

De Long NE, Hyslop JR, Raha S, Hardy DB and Holloway AC: Fluoxetine-induced pancreatic beta cell dysfunction: New insight into the benefits of folic acid in the treatment of depression. J Affect Disord. 166:6–13. 2014.PubMed/NCBI View Article : Google Scholar

Cataldo LR, Cortés VA, Mizgier ML, Aranda E, Mezzano D, Olmos P, Galgani JE, Suazo J and Santos JL: Fluoxetine impairs insulin secretion without modifying extracellular serotonin levels in MIN6 β-cells. Exp Clin Endocrinol Diabetes. 123:473–478. 2015.PubMed/NCBI View Article : Google Scholar

Grankvist K, Marklund SL and Täljedal IB: CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J. 199:393–398. 1981.PubMed/NCBI View Article : Google Scholar

Lenzen S, Drinkgern J and Tiedge M: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med. 20:463–466. 1996.PubMed/NCBI View Article : Google Scholar

Elmorsy E, Al-Ghafari A, Helaly ANM, Hisab AS, Oehrle B and Smith PA: Editor's highlight: Therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition. Toxicol Sci. 158:286–301. 2017.PubMed/NCBI View Article : Google Scholar

Dissanayake WC, Sorrenson B and Shepherd PR: The role of adherens junction proteins in the regulation of insulin secretion. Biosci Rep. 38(BSR20170989)2018.PubMed/NCBI View Article : Google Scholar

Chang HY, Chen SL, Shen MR, Kung ML, Chuang LM and Chen YW: Selective serotonin reuptake inhibitor, fluoxetine, impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells. Sci Rep. 7(3515)2017.PubMed/NCBI View Article : Google Scholar

Tharmaraja T, Stahl D, Hopkins CWP, Persaud SJ, Jones PM, Ismail K and Moulton CD: The association between selective serotonin reuptake inhibitors and glycemia: A systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 81:570–583. 2019.PubMed/NCBI View Article : Google Scholar

Ye Z, Chen L, Yang Z, Li Q, Huang Y, He M, Zhang S, Zhang Z, Wang X, Zhao W, et al: Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials. PLoS One. 6(e21551)2011.PubMed/NCBI View Article : Google Scholar

Liu B, Ruz-Maldonado I, Toczyska K, Olaniru OE, Zariwala MG, Hopkins D, Zhao M and Persaud SJ: The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass. Diabetes Obes Metab. 24:2038–2050. 2022.PubMed/NCBI View Article : Google Scholar

Flandreau EI, Bourke CH, Ressler KJ, Vale WW, Nemeroff CB and Owens MJ: Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala. Psychoneuroendocrinology. 38:1349–1361. 2013.PubMed/NCBI View Article : Google Scholar

Hansen CH, Larsen LW, Sørensen AM, Halling-Sørensen B and Styrishave B: The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line. Toxicol In Vitro. 41:1–11. 2017.PubMed/NCBI View Article : Google Scholar

Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H and Baumann P: Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: Relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl). 181:751–760. 2005.PubMed/NCBI View Article : Google Scholar

Jørgensen H, Knigge U, Kjær A, Møller M and Warberg J: Serotonergic stimulation of corticotropin-releasing hormone and pro-opiomelanocortin gene expression. J Neuroendocrinol. 14:788–795. 2002.PubMed/NCBI View Article : Google Scholar

Durell N, Franks R, Coon S, Cowart K and Carris NW: Effect of antidepressants on glucagon-like peptide-1 receptor agonist-related weight loss. J Pharm Technol. 38:283–288. 2022.PubMed/NCBI View Article : Google Scholar

Ilgin S, Kilic G, Baysal M, Kilic V, Korkut B, Ucarcan S and Atli O: Citalopram induces reproductive toxicity in male rats. Birth Defects Res. 109:475–485. 2017.PubMed/NCBI View Article : Google Scholar

Prasad P, Ogawa S and Parhar IS: Serotonin reuptake inhibitor citalopram inhibits GnRH synthesis and spermatogenesis in the male zebrafish. Biol Reprod. 93(102)2015.PubMed/NCBI View Article : Google Scholar

Koyuncu H, Serefoglu EC, Yencilek E, Atalay H, Akbas NB and Sarıca K: Escitalopram treatment for premature ejaculation has a negative effect on semen parameters. Int J Impot Res. 23:257–261. 2011.PubMed/NCBI View Article : Google Scholar

Sanchez C, Reines EH and Montgomery SA: A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? Int Clin Psychopharmacol. 29:185–196. 2014.PubMed/NCBI View Article : Google Scholar

Pastoor D and Gobburu J: Clinical pharmacology review of escitalopram for the treatment of depression. Expert Opin Drug Metab Toxicol. 10:121–128. 2014.PubMed/NCBI View Article : Google Scholar

Wu C, Gong WG, Wang YJ, Sun JJ, Zhou H, Zhang ZJ and Ren QG: Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity. Neurobiol Aging. 67:137–147. 2018.PubMed/NCBI View Article : Google Scholar

Benatti C, Alboni S, Blom JMC, Mendlewicz J, Tascedda F and Brunello N: Molecular changes associated with escitalopram response in a stress-based model of depression. Psychoneuroendocrinology. 87:74–82. 2018.PubMed/NCBI View Article : Google Scholar

Ronaldson A, Carvalho LA, Kostich K, Lazzarino AI, Urbanova L and Steptoe A: The effects of six-day SSRI administration on diurnal cortisol secretion in healthy volunteers. Psychopharmacology (Berl). 235:3415–3422. 2018.PubMed/NCBI View Article : Google Scholar

Tafet GE and Nemeroff CB: Pharmacological treatment of anxiety disorders: The role of the HPA axis. Front Psychiatry. 11(443)2020.PubMed/NCBI View Article : Google Scholar

Knorr U, Vinberg M, Gether U, Winkel P, Gluud C, Wetterslev J and Kessing LV: The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression-A randomised trial. Psychiatry Res. 200:354–360. 2012.PubMed/NCBI View Article : Google Scholar

Bourke CH, Stowe ZN, Neigh GN, Olson DE and Owens MJ: Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats. Neurotoxicol Teratol. 39:100–109. 2013.PubMed/NCBI View Article : Google Scholar

Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, Newport DJ, Cubells JF and Stowe ZN: DNA methylation in neonates born to women receiving psychiatric care. Epigenetics. 7:409–414. 2012.PubMed/NCBI View Article : Google Scholar

Nevels RM, Gontkovsky ST and Williams BE: Paroxetine-the antidepressant from hell? Probably not, but caution required. Psychopharmacol Bull. 46:77–104. 2016.PubMed/NCBI

Bourin M, Chue P and Guillon Y: Paroxetine: A review. CNS Drug Rev. 7:25–47. 2001.PubMed/NCBI View Article : Google Scholar

Jacobsen NW, Hansen CH, Nellemann C, Styrishave B and Halling-Sørensen B: Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicol In Vitro. 29:1729–1735. 2015.PubMed/NCBI View Article : Google Scholar

Jing E and Straw-Wilson K: Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Ment Health Clin. 6:191–196. 2016.PubMed/NCBI View Article : Google Scholar

Ulker N, Yardimci A, Kaya Tektemur N, Colakoglu N, Ozcan M, Canpolat S and Kelestimur H: Chronic exposure to paroxetine or bupropion modulates the pubertal maturation and the reproductive system in female rats. Reprod Biol. 20:154–163. 2020.PubMed/NCBI View Article : Google Scholar

Singh HK and Saadabadi A: Sertraline. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023.

Fuller RW, Hemrick-Luecke SK, Littlefield ES and Audia JE: Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo. Prog Neuropsychopharmacol Biol Psychiatry. 19:135–149. 1995.PubMed/NCBI View Article : Google Scholar

López-Muñoz F and Alamo C: Active metabolites as antidepressant drugs: The role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders. Front Psychiatry. 4(102)2013.PubMed/NCBI View Article : Google Scholar

Rothmore J: Antidepressant-induced sexual dysfunction. Med J Aust. 212:329–334. 2020.PubMed/NCBI View Article : Google Scholar

Lyons DJ, Ammari R, Hellysaz A and Broberger C: Serotonin and antidepressant SSRIs inhibit rat neuroendocrine dopamine neurons: Parallel actions in the lactotrophic axis. J Neurosci. 36:7392–7406. 2016.PubMed/NCBI View Article : Google Scholar

Munkboel CH, Larsen LW, Weisser JJ, Møbjerg Kristensen D and Styrishave B: Sertraline suppresses testis and adrenal steroid production and steroidogenic gene expression while increasing LH in plasma of male rats resulting in compensatory hypogonadism. Toxicol Sci. 163:609–619. 2018.PubMed/NCBI View Article : Google Scholar

Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ and Khan ZM: Antidepressant-induced sexual dysfunction. Ann Pharmacother. 36:1577–1589. 2002.PubMed/NCBI View Article : Google Scholar

Hamdi H: The preventive role of wheat germ oil against sertraline-induced testicular damage in male albino rats. Andrologia. 51(e13369)2019.PubMed/NCBI View Article : Google Scholar

Van der Paal J, Neyts EC, Verlackt CCW and Bogaerts A: Effect of lipid peroxidation on membrane permeability of cancer and normal cells subjected to oxidative stress. Chem Sci. 7:489–498. 2016.PubMed/NCBI View Article : Google Scholar

Atli O, Baysal M, Aydogan-Kilic G, Kilic V, Ucarcan S, Karaduman B and Ilgin S: Sertraline-induced reproductive toxicity in male rats: Evaluation of possible underlying mechanisms. Asian J Androl. 19:672–679. 2017.PubMed/NCBI View Article : Google Scholar

Pinney SE and Simmons RA: Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab. 21:223–229. 2010.PubMed/NCBI View Article : Google Scholar

De Long NE, Gutgesell MK, Petrik JJ and Holloway AC: Fetal exposure to sertraline hydrochloride impairs pancreatic β-cell development. Endocrinology. 156:1952–1957. 2015.PubMed/NCBI View Article : Google Scholar

Benfield P and Ward A: Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 32:313–334. 1986.PubMed/NCBI View Article : Google Scholar

Sukhatme VP, Reiersen AM, Vayttaden SJ and Sukhatme VV: Fluvoxamine: A review of its mechanism of action and its role in COVID-19. Front Pharmacol. 12(652688)2021.PubMed/NCBI View Article : Google Scholar

Anderson IM, Deakin JF and Miller HE: The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology (Berl). 128:74–82. 1996.PubMed/NCBI View Article : Google Scholar

Rinne T, de Kloet ER, Wouters L, Goekoop JG, de Rijk RH and van den Brink W: Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse. Neuropsychopharmacol. 28:126–132. 2003.PubMed/NCBI View Article : Google Scholar

Oishi A, Mochizuki Y, Otsu R and Inaba N: Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women. Biopsychosoc Med. 1(12)2007.PubMed/NCBI View Article : Google Scholar

Ishibashi Y, Izumo N, Iwata K, Morikawa T, Kameyama T, Watanabe Y, Manabe T and Matsuzaki H: Research and Report Fluvoxamine reverses estrogen-dependent decline in voluntary activities and decreased amygdala levels of serotonin in ovariectomized rats. J Brain Sci. 46:5–19. 2016.

Cella S, Pen̄alva A, Locatelli V, Novelli A, Cocchi D and Müller EE: Neuroendocrine studies with fluvoxamine: Animal data. Br J Clin Pharmacol. 15 (Suppl 3):357S–364S. 1983.PubMed/NCBI View Article : Google Scholar

Hosoi T, Miyahara T, Kayano T, Yokoyama S and Ozawa K: Fluvoxamine attenuated endoplasmic reticulum stress-induced leptin resistance. Front Endocrinol (Lausanne). 3(12)2012.PubMed/NCBI View Article : Google Scholar

Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T and Isenovic ER: Leptin and obesity: Role and clinical implication. Front Endocrinol (Lausanne). 12(585887)2021.PubMed/NCBI View Article : Google Scholar

Kotkowska Z and Strzelecki D: Depression and autoimmune hypothyroidism-their relationship and the effects of treating psychiatric and thyroid disorders on changes in clinical and biochemical parameters including BDNF and other cytokines-A systematic review. Pharmaceuticals (Basel). 15(391)2022.PubMed/NCBI View Article : Google Scholar

Caye A, Pilz LK, Maia AL, Hidalgo MP, Furukawa TA and Kieling C: The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 33:139–145. 2020.PubMed/NCBI View Article : Google Scholar

Baumgartner A, Dubeyko M, Campos-Barros A, Eravci M and Meinhold H: Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain. Brain Res. 635:68–74. 1994.PubMed/NCBI View Article : Google Scholar

de Carvalho GA, Bahls SC, Boeving A and Graf H: Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function. Thyroid. 19:691–697. 2009.PubMed/NCBI View Article : Google Scholar

Eker SS, Akkaya C, Ersoy C, Sarandol A and Kirli S: Reversible escitalopram-induced hypothyroidism. Gen Hosp Psychiatry. 32:559.e5–e7. 2010.PubMed/NCBI View Article : Google Scholar

Takahashi M, Sawayama E, Sawayama T and Miyaoka H: Reversible paroxetine-induced symptomatic hypothyroidism. Pharmacopsychiatry. 40:201–202. 2007.PubMed/NCBI View Article : Google Scholar

Cooper-Kazaz R and Lerer B: Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol. 11:685–699. 2008.PubMed/NCBI View Article : Google Scholar

Hage M and Azar ST: The link between thyroid function and depression. J Thyroid Res. 2012(590648)2012.PubMed/NCBI View Article : Google Scholar

Jackson IM: Does thyroid hormone have a role as adjunctive therapy in depression? Thyroid. 6:63–7. 1996.PubMed/NCBI View Article : Google Scholar